-
US indices finished yesterday's trading mixed. S&P 500 gained 0.29%, Nasdaq added 1.05%, Dow Jones dropped 0.20% and Russell 2000 declined 0.22%
-
Stocks in Asia traded mostly higher. S&P/ASX 200 gained 0.6%, Kospi moved 0.5% higher and indices from China advanced. Nikkei was a laggard as it dropped 0.3%
-
DAX futures point to a higher opening of the European session
-
The Reserve Bank of New Zealand kept interest rates unchanged at today's meeting as well as refrained from making changes to its lending and asset purchase programmes. RBNZ reminded that the economic outlook remains highly uncertain.
-
Use of Johnson & Johnson coronavirus vaccine has been paused in all 50 US states amid blood clot cases. Vaccine rollout in Europe has also been delayed
-
Moderna released long-term trial results showing a 90% effectiveness 6 months after receiving second dose
-
Japanese machinery orders declined 8.5% MoM in February (exp. +2.4% MoM)
-
API report pointed to a 3.61 million barrel decline in oil inventories
-
Bitcoin trades at fresh record highs near $64,000. Coinbase, US largest cryptocurrency exchange, will go public on Wall Street later today
-
Precious metals trade mixed - gold and palladium drop while platinum and silver gain. Oil trades slightly higher. Industrial metals trade mixed
-
NZD and AUD are the best performing major currencies while CAD, USD and CHF lag the most
Nasdaq 100 (US100) managed to jump above the mid-February peak and has reached a fresh record high. US tech index trades just a touch below the 14,000 mark and it could turn out to be a short-term psychological resistance . Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
